IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 129 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $301,000 | -3.5% | 19,662 | 0.0% | 0.09% | +3.6% |
| Q3 2016 | $312,000 | +21.4% | 19,662 | 0.0% | 0.08% | +31.2% |
| Q2 2016 | $257,000 | +19.5% | 19,662 | 0.0% | 0.06% | +18.5% |
| Q1 2016 | $215,000 | -5.7% | 19,662 | 0.0% | 0.05% | -1.8% |
| Q4 2015 | $228,000 | +11.2% | 19,662 | 0.0% | 0.06% | -5.2% |
| Q3 2015 | $205,000 | -13.5% | 19,662 | 0.0% | 0.06% | -12.1% |
| Q2 2015 | $237,000 | -24.8% | 19,662 | 0.0% | 0.07% | -20.5% |
| Q1 2015 | $315,000 | +4.7% | 19,662 | 0.0% | 0.08% | +6.4% |
| Q4 2014 | $301,000 | +18.0% | 19,662 | 0.0% | 0.08% | +2.6% |
| Q3 2014 | $255,000 | -15.3% | 19,662 | 0.0% | 0.08% | -8.4% |
| Q2 2014 | $301,000 | +24.4% | 19,662 | 0.0% | 0.08% | +18.6% |
| Q1 2014 | $242,000 | +6.1% | 19,662 | 0.0% | 0.07% | +2.9% |
| Q4 2013 | $228,000 | -2.1% | 19,662 | 0.0% | 0.07% | -6.8% |
| Q3 2013 | $233,000 | +19.5% | 19,662 | 0.0% | 0.07% | +23.7% |
| Q2 2013 | $195,000 | – | 19,662 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |